Madonna Achkar1, Linda Dodds2, Yves Giguère3, Jean-Claude Forest3, B Anthony Armson4, Christy Woolcott2, Sherry Agellon1, Anne Spencer2, Hope A Weiler5. 1. School of Dietetics and Human Nutrition, McGill University, Ste. Anne de Bellevue, Quebec, Canada. 2. Perinatal Epidemiology Research Unit, Dalhousie University and Izaak Walton Killam Health Centre, Halifax, Nova Scotia, Canada. 3. Centre Hospitalier Universitaire de Québec Research Center and Department of Molecular Biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Quebec City, Quebec, Canada. 4. Department of Obstetrics and Gynecology, Dalhousie University and Izaak Walton Killam Health Centre, Halifax, Nova Scotia, Canada. 5. School of Dietetics and Human Nutrition, McGill University, Ste. Anne de Bellevue, Quebec, Canada. Electronic address: hope.weiler@mcgill.ca.
Abstract
OBJECTIVE: We sought to examine the association between maternal serum 25-hydroxyvitamin D (25[OH]D) concentration in early pregnancy and the subsequent diagnosis of preeclampsia (PE). STUDY DESIGN: This was a nested case-control study from 2 prospective Canadian cohorts conducted in Quebec City, Quebec, and Halifax, Nova Scotia, from 2002 through 2010. Participants were pregnant women (n = 169 cases with PE and 1975 controls). Maternal serum was drawn <20 weeks of gestation, and 25(OH)D measurement was performed. Cases were ascertained from medical records. Logistic regression analysis was used to estimate adjusted odds ratios with 95% confidence intervals. RESULTS: Women who developed PE had a significantly lower 25(OH)D concentration at a mean gestational age of 14 weeks compared with women in the control group (mean ± SD 25[OH]D 47.2 ± 17.7 vs 52.3 ± 17.2 nmol/L, P < .0001). Women with 25(OH)D <30 nmol/L compared to those with at least 50 nmol/L had a greater risk of developing PE (adjusted odds ratio, 2.23; 95% confidence interval, 1.29-3.83) after adjustment for prepregnancy body mass index, maternal age, smoking, parity, season and year of blood collection, gestational week at blood collection, and cohort site. Exploratory analysis with cubic splines demonstrated a dose-response relationship between maternal 25(OH)D and risk of PE, up to levels around 50 nmol/L, where the association appeared to plateau. CONCLUSION: Maternal vitamin D deficiency early in pregnancy defined as 25(OH)D <30 nmol/L may be an independent risk factor for PE. The relevance of vitamin D supplementation for women of childbearing age should be explored as a strategy for reducing PE and for promoting a healthier pregnancy.
OBJECTIVE: We sought to examine the association between maternal serum 25-hydroxyvitamin D (25[OH]D) concentration in early pregnancy and the subsequent diagnosis of preeclampsia (PE). STUDY DESIGN: This was a nested case-control study from 2 prospective Canadian cohorts conducted in Quebec City, Quebec, and Halifax, Nova Scotia, from 2002 through 2010. Participants were pregnant women (n = 169 cases with PE and 1975 controls). Maternal serum was drawn <20 weeks of gestation, and 25(OH)D measurement was performed. Cases were ascertained from medical records. Logistic regression analysis was used to estimate adjusted odds ratios with 95% confidence intervals. RESULTS:Women who developed PE had a significantly lower 25(OH)D concentration at a mean gestational age of 14 weeks compared with women in the control group (mean ± SD 25[OH]D 47.2 ± 17.7 vs 52.3 ± 17.2 nmol/L, P < .0001). Women with 25(OH)D <30 nmol/L compared to those with at least 50 nmol/L had a greater risk of developing PE (adjusted odds ratio, 2.23; 95% confidence interval, 1.29-3.83) after adjustment for prepregnancy body mass index, maternal age, smoking, parity, season and year of blood collection, gestational week at blood collection, and cohort site. Exploratory analysis with cubic splines demonstrated a dose-response relationship between maternal 25(OH)D and risk of PE, up to levels around 50 nmol/L, where the association appeared to plateau. CONCLUSION: Maternal vitamin D deficiency early in pregnancy defined as 25(OH)D <30 nmol/L may be an independent risk factor for PE. The relevance of vitamin D supplementation for women of childbearing age should be explored as a strategy for reducing PE and for promoting a healthier pregnancy.
Authors: Irene M van der Meer; Nasra S Karamali; A Joan P Boeke; Paul Lips; Barend J C Middelkoop; Irene Verhoeven; Jan D Wuister Journal: Am J Clin Nutr Date: 2006-08 Impact factor: 7.045
Authors: Alice R Rumbold; Caroline A Crowther; Ross R Haslam; Gustaaf A Dekker; Jeffrey S Robinson Journal: N Engl J Med Date: 2006-04-27 Impact factor: 91.245
Authors: M Grundmann; M Haidar; S Placzko; R Niendorf; N Darashchonak; C A Hubel; F von Versen-Höynck Journal: Am J Physiol Cell Physiol Date: 2012-08-29 Impact factor: 4.249
Authors: Arthur M Baker; Sina Haeri; Carlos A Camargo; Janice A Espinola; Alison M Stuebe Journal: J Clin Endocrinol Metab Date: 2010-08-18 Impact factor: 5.958
Authors: Linda Dodds; Deshayne B Fell; Kent C Dooley; B Anthony Armson; Alexander C Allen; Bassam A Nassar; Sherry Perkins; K S Joseph Journal: Clin Chem Date: 2007-12-10 Impact factor: 8.327
Authors: R Gupta; M Dhyani; T Kendzerska; S R Pandi-Perumal; A S BaHammam; P Srivanitchapoom; S Pandey; M Hallett Journal: Acta Neurol Scand Date: 2015-10-19 Impact factor: 3.209
Authors: Hooman Mirzakhani; Augusto A Litonjua; Thomas F McElrath; George O'Connor; Aviva Lee-Parritz; Ronald Iverson; George Macones; Robert C Strunk; Leonard B Bacharier; Robert Zeiger; Bruce W Hollis; Diane E Handy; Amitabh Sharma; Nancy Laranjo; Vincent Carey; Weilliang Qiu; Marc Santolini; Shikang Liu; Divya Chhabra; Daniel A Enquobahrie; Michelle A Williams; Joseph Loscalzo; Scott T Weiss Journal: J Clin Invest Date: 2016-11-14 Impact factor: 14.808
Authors: Rachel S Kelly; Damien C Croteau-Chonka; Amber Dahlin; Hooman Mirzakhani; Ann C Wu; Emily S Wan; Michael J McGeachie; Weiliang Qiu; Joanne E Sordillo; Amal Al-Garawi; Kathryn J Gray; Thomas F McElrath; Vincent J Carey; Clary B Clish; Augusto A Litonjua; Scott T Weiss; Jessica A Lasky-Su Journal: Metabolomics Date: 2016-12-12 Impact factor: 4.290